ALLO
ALLOGENE THERAP (ALLO)
NASDAQ
$2.01+$0.010 (+0.50%)
Price as of Jun 03, 2026 7:58 PM EDT
  • $749.0M
    Market Cap
  • 51.85%
    1-Year Change
  • Biotechnology
    Industry
ALLO
vs History
vs S&P 500
General Statistics
Latest Close
$2.00
Change
-$0.10 (-4.65%)
Open
$2.07
High
$2.07
Low
$1.96
Previous Close
$2.05
Volume
9,057,142
30-Day Average Volume
6,860,048
1-Week Change
-3.30%
1-Month Change
-4.65%
1-Year Change
51.85%
3-Year Change
-63.46%
5-Year Change
-91.74%
Fundamentals
Shares Outstanding
345.2M
Total Assets
$396.0M
Market Cap
$749.0M
Enterprise Value
$718.7M
Period:
QTR
TTM
FY
Revenue
N/A
Net Income
-$42.6M
Free Cash Flow
-$12.9M
EBIT
-$42.6M
EBITDA
-$39.7M
Net Working Capital
$245.0M
EPS
-$0.18
Enterprise Value/EBITDA
-18
Enterprise Value/Revenue
N/A
P/B
3
P/E
-12
PEG
2
Price/Free Cash Flow
-58
Price/Operating Cash Flow
-58
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue